Citius Pharmaceuticals, Inc.
USD0.59
+0.01 (+1.62%)
CEO
Leonard L. Mazur
IPO Date
2014-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.59
Prev. Close
$0.58
Day Low
$0.58
Day High
$0.60
52W Low
$0.48
52W High
$2.48
Market Cap
$0.01B
Volume
0.12M
| -3.7 |
| 30 Sept 2023 | FY | 0.0% | 0.0% | -35.8% | -31.4% | 0.01 | 5.95 | -5.1 |
| 30 Sept 2022 | FY | 0.0% | 0.0% | -32.7% | -29.5% | 0.01 | 9.84 | -8.8 |
| 30 Sept 2021 | FY | 0.0% | 0.0% | -17.5% | -16.2% | 0.01 | 18.28 | -15.9 |
| 30 Sept 2020 | FY | 0.0% | 0.0% | -52.1% | -40.1% | 0.04 | 3.41 | -3.9 |
| 30 Sept 2019 | FY | 0.0% | 0.0% | -63.9% | -53.7% | 0.01 | 1.72 | -1.6 |
| 30 Sept 2018 | FY | 0.0% | 0.0% | -45.0% | -40.4% | 0.01 | 3.16 | -2.4 |
| 30 Sept 2017 | FY | 0.0% | 0.0% | -47.3% | -42.5% | 0.01 | 1.39 | -2.8 |
| 30 Sept 2016 | FY | 0.0% | 0.0% | -49.5% | -37.8% | 0.04 | 0.17 | -6.9 |
| -0.5 |
| 30 Sept 2025 | Q4 | 0.0% | 0.0% | -11.8% | -6.1% | 0.03 | 0.62 | -0.7 |
| 30 Jun 2025 | Q3 | 0.0% | 0.0% | -13.5% | -6.9% | 0.03 | 0.47 | -0.5 |
| 31 Mar 2025 | Q2 | 0.0% | 0.0% | -18.0% | -9.0% | 0.02 | 0.37 | -0.4 |
| 31 Dec 2024 | Q1 | 0.0% | 0.0% | -14.9% | -8.1% | 0.00 | 0.41 | -1.2 |
| 30 Sept 2024 | Q4 | -34.4% | -6920.1% | -15.4% | -9.2% | 0.00 | 0.40 | -3.4 |
| 30 Jun 2024 | Q3 | 0.0% | 0.0% | -12.3% | -10.9% | 0.00 | 6.75 | -3.7 |
| 31 Mar 2024 | Q2 | 0.0% | 0.0% | -10.8% | -9.4% | 0.00 | 5.17 | -8.0 |
| 31 Dec 2023 | Q1 | 0.0% | 0.0% | -10.9% | -9.5% | 0.01 | 5.06 | -5.4 |